Medicus Pharma [MDPLD] vs AbbVie [ABBV] Detailed Stock Comparison

Medicus Pharma Ltd.

NASDAQ
Loading...

AbbVie Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Medicus Pharma Ltd. wins in 2 metrics, AbbVie Inc. wins in 9 metrics, with 1 ties. AbbVie Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medicus Pharma Ltd. AbbVie Inc. Better
P/E Ratio (TTM) -1.47 83.46 AbbVie Inc.
Price-to-Book Ratio 3.90 -108.79 Medicus Pharma Ltd.
Debt-to-Equity Ratio 0.10 -21.19 Medicus Pharma Ltd.
PEG Ratio N/A -0.01 N/A
EV/EBITDA 0.00 14.31 Tie
Profit Margin (TTM) 0.00% 6.91% AbbVie Inc.
Operating Margin (TTM) 0.00% 34.11% AbbVie Inc.
EBITDA Margin (TTM) N/A 34.11% N/A
Return on Equity -841.91% 6,225.00% AbbVie Inc.
Return on Assets (TTM) -358.37% 9.81% AbbVie Inc.
Free Cash Flow (TTM) $-4.16M $17.82B AbbVie Inc.
Dividend Yield N/A 3.10% N/A
1-Year Return N/A 19.18% N/A
Price-to-Sales Ratio (TTM) N/A 5.72 N/A
Enterprise Value $0 $418.50B AbbVie Inc.
EV/Revenue Ratio N/A 6.84 N/A
Gross Profit Margin (TTM) N/A 72.61% N/A
Revenue per Share (TTM) $0 $35 AbbVie Inc.
Earnings per Share (Diluted) $-2.54 $2.37 AbbVie Inc.
Beta (Stock Volatility) N/A 0.36 N/A
Short % of Float N/A 1.27% N/A

Medicus Pharma Ltd. vs AbbVie Inc. Stock Performance Analysis

Loading Price Chart...

MDPLD
ABBV

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medicus Pharma Ltd.1.78%0.00%0.00%0.00%0.00%0.00%
AbbVie Inc.0.04%2.58%8.40%22.13%18.90%10.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medicus Pharma Ltd.N/AN/AN/AN/AN/AN/A
AbbVie Inc.19.18%64.26%101.32%279.49%590.09%590.09%

Performance & Financial Health Analysis: Medicus Pharma Ltd. vs AbbVie Inc.

MetricMDPLDABBV
Market Information
Market Cap iN/A$351.47B
Market Cap CategoryN/AMega cap
10 Day Avg. Volume i20,0916,251,101
90 Day Avg. Volume i36,7126,859,587
Last Close$2.86$254.49
52 Week Range$1.80 - $6.00$184.63 - $261.64
% from 52W High-52.33%-2.73%
All-Time High$3.00 (Jan 24, 2025)$261.64 (Jul 02, 2026)
% from All-Time High-4.67%-2.73%
Growth Metrics
Quarterly Revenue GrowthN/A0.10%
Quarterly Earnings GrowthN/A0.10%
Financial Health
Profit Margin (TTM) i0.00%0.07%
Operating Margin (TTM) i0.00%0.34%
Return on Equity (TTM) i-8.42%62.25%
Debt to Equity (MRQ) i0.10-21.19
Cash & Liquidity
Book Value per Share (MRQ)$0.73$-1.85
Cash per Share (MRQ)N/A$2.97
Operating Cash Flow (TTM) i$-4,987,008$19.03B
Levered Free Cash Flow (TTM) i$-6,784,140$18.34B
Dividends
Last 12-Month Dividend Yield iN/A3.10%
Last 12-Month Dividend iN/A$6.65

Valuation & Enterprise Metrics Analysis: Medicus Pharma Ltd. vs AbbVie Inc.

MetricMDPLD (Mar 31, 2025)ABBV (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-1.4783.46
Forward P/E iN/A12.30
PEG Ratio iN/A-0.01
Price to Sales (TTM) iN/A5.72
Price to Book (MRQ) i3.90-108.79
Market Capitalization
Market Capitalization i$22.45M$351.47B
Enterprise Value i$0$418.50B
Enterprise Value Metrics
Enterprise to Revenue iN/A6.84
Enterprise to EBITDA i0.0014.31
Risk & Other Metrics
Beta iN/A0.36
Book Value per Share (MRQ) i$0.73$-1.85

Financial Statements Comparison: Medicus Pharma Ltd. vs AbbVie Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMDPLD (2023)ABBV (2025)
Revenue/Sales i061.16B
Cost of Goods Sold iN/A18.20B
COGS % of Revenue i-29.8%
Gross Profit iN/A42.96B
Gross Margin i-70.2%
Research & Development i193,5789.10B
Operating Income (EBIT) i-3.01M20.09B
Operating Margin i-32.8%
EBITDA i-6.72M22.70B
EBITDA Margin i-37.1%
Pre-Tax Income i-6.78M6.60B
Pre-Tax Income % of Revenue i-10.8%
Income Tax iN/A2.36B
Income Tax % of Revenue i-3.9%
Net Income (Profit) i-6.78M4.23B
Profit Margin i-6.9%

Balance Sheet & Liquidity Metrics

MetricMDPLD (2023)ABBV (2025)
Cash & Equivalents i1.72M5.23B
Total Current Assets i1.89M29.06B
Total Current Assets % of Revenue i-47.5%
Total Current Liabilities i1.09M43.29B
Total Current Liabilities % of Revenue i-70.8%
Long-Term Debt iN/A58.94B
Long-Term Debt % of Revenue i-96.4%
Total Shareholders Equity i805,800-3.23B
Retained Earnings i-19.18M-15.49B
Retained Earnings % of Revenue i--25.3%
Property, Plant & Equipment iN/A8.79B

Cash Flow Statement Comparison

MetricMDPLD (2023)ABBV (2025)
Operating Cash Flow i-4.99M19.94B
Operating Cash Flow % of Revenue i-32.6%
Capital Expenditures iN/A-1.21B
Free Cash Flow i-4.16M17.82B
FCF Margin i-29.1%
Debt Repayment iN/A-9.60B
Common Stock Repurchase iN/A-980.00M

Short Interest & Institutional Ownership Analysis

MetricMDPLDABBV
Shares Short iN/A20.13M
Short Ratio iN/A2.67
Short % of Float iN/A1.27%
Shares Outstanding i8.08M1.77B
Float Shares iN/A1.77B
% Held by Insiders i55.81%0.12%
% Held by Institutions i0.00%76.78%
% Held by Public i44.19%23.10%

Dividend Analysis & Yield Comparison: Medicus Pharma Ltd. vs AbbVie Inc.

MetricMDPLDABBV
Last 12-Month Dividend iN/A$6.65
Last 12-Month Dividend Yield iN/A3.10%
3-Year Avg Annual Dividend iN/A$6.31
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$18.93
Ex-Dividend DateN/AJan 16, 2026